NEW WEBSITE
• GALI and HLY, new results, new validations, new perspectives:
Trends and variations in activity limitations in Europe by Jean Marie Robine
Validations studies: an overview by Herman Van Oyen
Impact of changing the wording of the GALI on the prevalence of activity limitation: the case of France by Emmanuelle Cambois
New versions of the GALI proposed by Eurostat by Stefaan Demarest
• Use of the GALI and the HLY by the European Commission and the Member States
Introduction and overview by Petronille Bogaert
GALI and HLY in the Czech Republic by Sarka Dankova
Expected lifetime without and with mild and severe activity limitations at age 65 in Denmark, 2006-2013 by Ingelise Andersen
Healthy life expectancy, an indispensable indicator for public debate by Gerard Badeyan
Life expectancy and healthy life-years in Estonia by Mare Ruuge
Life expectancy and healthy life-years in Estonia by Mika Gissler
Use of GALI and the HLY in Germany by Angela Fehr
Healthy Life Years in Hungary - Briefly by Andras Weber
Prevalence of GALI: does the choice of survey matter? by Wilma Nusselder
Contribution of chronic conditions to smoking differences in LE, DFLE, and LED in Belgium, 2001-2004 by Renata Yokota
Use of the GALI and the HLY: case of Latvia by Juris Krumins
Effect on life and health expectancy by closing an abridged life table at 90+ and through modification of the imputation method in the UK 2013-15 by Asim Butt and Chris White
Healthy life years - Slovenia by Tina Lesnik